ArticleTobacco induced diseases2025
Tobacco-related lung cancer burden in the Western Pacific Region from 1990 to 2021: An age-period-cohort analysis from the Global Burden of Disease Study.
Article in Tobacco induced diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Diseases burden and trends of bladder cancer attributable to behavioral and metabolic factors among global and Chinese population, 1990-2021: results from the global burden of disease study 2021.Journal of health, population, and nutrition · 2025Article
- Burden and Trends of Nasopharyngeal Cancer Among Younger People in the Western Pacific Region, 1990 to 2021: Findings from the 2021 Global Burden of Disease Study.Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-facialeArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionLung cancer is a significant health issue in the Western Pacific region, where tobacco use is highly prevalent. This study examines the trends in tobacco-related lung cancer burden from 1990 to 2021, offering insights into the evolution of this critical public health challenge.
methodsThis study uses data from the Global Burden of Disease (GBD) 2021 study to analyze lung cancer rates. It employs an age-period-cohort analysis to explore patterns in mortality and disability-adjusted life-years (DALYs) attributed to tobacco-related lung cancer. The study also uses joinpoint regression analysis to pinpoint changes over different periods.
resultsOur analyses revealed a substantial rise in both the number of deaths and DALYs due to tobacco-related lung cancer in the Western Pacific region from 1990 to 2021. Total deaths increased by 163.42% to 644.5 thousand (95% UI: 517.9-793.8) in 2021, which is 2.6 times the global growth rate of 63.25%. While global ASMR decreased by 25.46%, the Western Pacific Region showed minimal change with a slight increase (AAPC=0.08). SDI analysis revealed an inverse relationship with burden - for example, Singapore's ASMR decreased from 20.4 to 7.0 per 100000 population (high SDI) while China's increased from 23.8 to 25.8 (middle SDI). Age-period-cohort analysis showed the net drift of lung cancer mortality was -0.16% per year. The fastest increase in ASMR occurred between 1998-2004 (APC=1.53%), followed by the steepest decline during 2004-2007 (APC= -1.49%).
conclusionsThe Western Pacific region continues to face a high burden of tobacco-related lung cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.